128 related articles for article (PubMed ID: 8687154)
1. Efficacy of the association of 13-cis-retinoic acid (13cRA) and alpha-interferon 2a (alpha-IFN 2a) in moderate-severe cervical intraepithelial neoplasia (CIN II-III): a pilot study.
Toma S; Ragni N; Raffo P; Boselli F; Gustavino C; Rugiati S; Formelli F; Palumbo R; Rosso R; De Cecco L
Anticancer Res; 1996; 16(2):931-6. PubMed ID: 8687154
[TBL] [Abstract][Full Text] [Related]
2. Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
Snoeck R; Noel JC; Muller C; De Clercq E; Bossens M
J Med Virol; 2000 Feb; 60(2):205-9. PubMed ID: 10596022
[TBL] [Abstract][Full Text] [Related]
3. Cytokine serum levels in patients with cervical intraepithelial neoplasia grade II-III treated with intralesional interferon-α 2b.
Misson DR; Abdalla DR; Borges AM; Shimba DS; Adad SJ; Michelin MA; Murta EF
Tumori; 2011; 97(5):578-84. PubMed ID: 22158487
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human interferon gamma in the treatment of cervical intraepithelial neoplasia (CIN) associated with human papillomavirus (HPV) infection.
Sikorski M; Zrubek H
Eur J Gynaecol Oncol; 2003; 24(2):147-50. PubMed ID: 12701965
[TBL] [Abstract][Full Text] [Related]
5. A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.
Park YC; Ouh YT; Sung MH; Park HG; Kim TJ; Cho CH; Park JS; Lee JK
J Gynecol Oncol; 2019 Nov; 30(6):e88. PubMed ID: 31576684
[TBL] [Abstract][Full Text] [Related]
6. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
[TBL] [Abstract][Full Text] [Related]
7. Intralesional beta-interferon treatment of cervical intraepithelial neoplasia associated with human papillomavirus infection.
Penna C; Fallani MG; Gordigiani R; Sonni L; Taddei GL; Marchionni M
Tumori; 1994 Apr; 80(2):146-50. PubMed ID: 8016908
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinoma.
Toma S; Palumbo R; Vincenti M; Aitini E; Paganini G; Pronzato P; Grimaldi A; Rosso R
Ann Oncol; 1994 May; 5(5):463-5. PubMed ID: 8075053
[TBL] [Abstract][Full Text] [Related]
9. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.
Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM
Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236
[TBL] [Abstract][Full Text] [Related]
10. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Holdener E; Krakoff IH
J Natl Cancer Inst; 1992 Feb; 84(4):241-5. PubMed ID: 1734085
[TBL] [Abstract][Full Text] [Related]
11. [beta-Interferon in the therapy of cervico-vaginal papilloma virus (HPV) infection associated with cervical intraepithelial neoplasia (CIN)].
Grismondi GL; Masin G; Marini A
Minerva Ginecol; 1995 Dec; 47(12):527-9. PubMed ID: 8720973
[TBL] [Abstract][Full Text] [Related]
12. A 2-week pretreatment with 13-cis-retinoic acid + interferon-alpha-2a prior to definitive radiation improves tumor tissue oxygenation in cervical cancers.
Dunst J; Hänsgen G; Krause U; Füchsel G; Köhler U; Becker A
Strahlenther Onkol; 1998 Nov; 174(11):571-4. PubMed ID: 9830438
[TBL] [Abstract][Full Text] [Related]
13. [Role of immunomodulatory treatment with Iscador QuS and Intron A of women with CIN1 with concurrent HPV infection].
Jach R; Basta A; Szczudrawa A
Ginekol Pol; 2003 Sep; 74(9):729-35. PubMed ID: 14674116
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of selected MHC class I and II molecule expression in the course of HPV positive CIN treatment with the use of human recombinant IFN-gamma.
Sikorski M; Bobek M; Zrubek H; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2004 Mar; 83(3):299-307. PubMed ID: 14995928
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of immune system cell infiltrate in the cervical stroma of patients with grade III cervical intraepithelial neoplasia after treatment with intralesional alpha-2B interferon.
Machado FA; Abdalla DR; Montes L; Etchebehere RM; Michelin MA; Murta EF
Eur J Gynaecol Oncol; 2014; 35(1):20-5. PubMed ID: 24654456
[TBL] [Abstract][Full Text] [Related]
16. Immunological evaluation of vaginal secretion in patients with high-grade cervical intraepithelial neoplasia treated with intralesional interferon alpha-2b.
Mardegan MC; Ramos MC; Adad SJ; Michelin MA; Shimba D; Murta EF
Eur J Gynaecol Oncol; 2011; 32(3):297-302. PubMed ID: 21797121
[TBL] [Abstract][Full Text] [Related]
17. [Iscador QuS and human recombinant interferon alpha (Intron A) in cervical intraepithelial neoplasia (CIN)].
Jach R; Basta A
Przegl Lek; 1999; 56(1):86-8. PubMed ID: 10375935
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular interferon-beta treatment of cervical intraepithelial neoplasia II associated with human papillomavirus infection.
De Aloysio D; Miliffi L; Iannicelli T; Penacchioni P; Bottiglioni F
Acta Obstet Gynecol Scand; 1994 May; 73(5):420-4. PubMed ID: 8009976
[TBL] [Abstract][Full Text] [Related]
19. Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).
Kaufmann AM; Nieland JD; Jochmus I; Baur S; Friese K; Gabelsberger J; Gieseking F; Gissmann L; Glasschröder B; Grubert T; Hillemanns P; Höpfl R; Ikenberg H; Schwarz J; Karrasch M; Knoll A; Küppers V; Lechmann M; Lelle RJ; Meissner H; Müller RT; Pawlita M; Petry KU; Pilch H; Walek E; Schneider A
Int J Cancer; 2007 Dec; 121(12):2794-800. PubMed ID: 17721997
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study.
Park TK; Lee JP; Kim SN; Choi SM; Kudelka AP; Kavanagh JJ
Eur J Gynaecol Oncol; 1998; 19(1):35-8. PubMed ID: 9476056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
